title: Intracorporal injection of hSlo cDNA restores erectile capacity in STZ-diabetic F-344 rats in vivo.
abstract: The ability of gene transfer with the pore-forming subunit of the human maxi-K channel (hSlo) to ameliorate the decline in erectile capacity commensurate with 12-24 wk of streptozotocin (STZ)-diabetes was examined in 181 Fischer-344 rats. A 2-mo period of STZ-diabetes was induced before gene transfer, and erectile capacity was evaluated by measuring the intracavernous pressure response (ICP) to cavernous nerve (CN) stimulation (ranging from 0.5 to 10 mA). In the first series of experiments, ANOVA revealed increased CN-stimulated ICP responses at 1 and 2 mo postinjection of 100 microg pcDNA-hSlo compared with control values. A second series of experiments further examined the dose dependence and duration of gene transfer. The ICP response to submaximal (0.5 mA) and maximal (10 mA) nerve stimulation was evaluated 3 or 4 mo postinjection of a single dose of pcDNA-hSlo ranging from 10 to 1,000 microg. ANOVA again revealed that hSlo overexpression was associated with increased CN-stimulated ICP responses compared with responses in corresponding control animals. Histological studies revealed no immune response to the presence of hSlo. PCR analysis documented that expression of both plasmid and transcript were largely confined to the corporal tissue. In the third series of pharmacological experiments, hSlo gene transfer in vivo was associated with iberiotoxin-sensitive relaxation responses to sodium nitroprusside in corporal tissue strips in vitro. The latter data indicate that gene transfer produces functional maxi-K channels that participate in the modulation of corporal smooth muscle cell tone. Taken together, these observations suggest a fundamental diabetes-related change in corporal myocyte maxi-K channel regulation, expression, or function that may be corrected by expression of recombinant hSlo.
authors.affiliation: Department of Urology, Institute for Smooth Muscle Biology, Rm. 744, Forchheimer Bldg., Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461. christ@aecom.yu.edu
authors.forename: George J
authors.initials: GJ
authors.lastname: Christ
authors.forename: Nancy
authors.initials: N
authors.lastname: Day
authors.forename: Cristian
authors.initials: C
authors.lastname: Santizo
authors.forename: Yoshi
authors.initials: Y
authors.lastname: Sato
authors.forename: Weixin
authors.initials: W
authors.lastname: Zhao
authors.forename: Theresa
authors.initials: T
authors.lastname: Sclafani
authors.forename: Ron
authors.initials: R
authors.lastname: Bakal
authors.forename: Masha
authors.initials: M
authors.lastname: Salman
authors.forename: Kelvin
authors.initials: K
authors.lastname: Davies
authors.forename: Arnold
authors.initials: A
authors.lastname: Melman
mesh_terms: D000818:Animals; D001835:Body Weight; D018076:DNA, Complementary / Q000494:pharmacology; D003921:Diabetes Mellitus, Experimental / Q000150:complications*; D007172:Erectile Dysfunction / Q000209:etiology* / Q000628:therapy*; D015870:Gene Expression; D015316:Genetic Therapy; D051036:Large-Conductance Calcium-Activated Potassium Channels; D008297:Male; D024681:Potassium Channels, Calcium-Activated / Q000235:genetics*; D011312:Pressure; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D018076:DNA, Complementary; D051036:Large-Conductance Calcium-Activated Potassium Channels; D024681:Potassium Channels, Calcium-Activated